311 related articles for article (PubMed ID: 11836639)
41. Metabolic functions of the lung and systemic vasoregulation.
Pitt BR
Fed Proc; 1984 Aug; 43(11):2574-7. PubMed ID: 6086408
[TBL] [Abstract][Full Text] [Related]
42. ACE inhibition accelerates endothelial regrowth in vivo: a possible explanation for the benefit observed with ACE inhibitors following arterial injury.
Van Belle E; Meurice T; Tio FO; Corseaux D; Dupuis B; McFadden EP; Lablanche JM; Bauters C; Bertrand ME
Biochem Biophys Res Commun; 1997 Feb; 231(3):577-81. PubMed ID: 9070849
[TBL] [Abstract][Full Text] [Related]
43. [Angiotensin-converting enzyme in pulmonary thromboembolism as a marker of vascular lesion].
Muñoz Méndez J; Alfajeme Michavila I; Hernández Borge J; Martínez Muñoz I; Ortega Cuesta B; Alvarez-Sala Walther R; Sánchez Gascón F; Villamor León J
Rev Clin Esp; 1997 Feb; 197(2):84-91. PubMed ID: 9213862
[TBL] [Abstract][Full Text] [Related]
44. Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat.
van Dijk DJ; Boner G; Giler S; Erman A
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):193-8. PubMed ID: 11881122
[TBL] [Abstract][Full Text] [Related]
45. Activity of serum angiotensin converting enzyme in septic pigs treated with intrapulmonary corticosteroid.
Walther S; Berg S; Jansson I; Lennquist S
Eur J Surg; 1994 Jan; 160(1):3-7. PubMed ID: 8186310
[TBL] [Abstract][Full Text] [Related]
46. Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response.
Richardson MA; Gupta A; O'Brien LA; Berg DT; Gerlitz B; Syed S; Sharma GR; Cramer MS; Heuer JG; Galbreath EJ; Grinnell BW
J Pharmacol Exp Ther; 2008 Apr; 325(1):17-26. PubMed ID: 18182560
[TBL] [Abstract][Full Text] [Related]
47. Superior cavopulmonary anastomosis suppresses the activity and expression of pulmonary angiotensin-converting enzyme.
Malhotra SP; Riemer RK; Thelitz S; He YP; Hanley FL; Reddy VM
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):464-9. PubMed ID: 11547295
[TBL] [Abstract][Full Text] [Related]
48. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
49. Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension.
Orte C; Polak JM; Haworth SG; Yacoub MH; Morrell NW
J Pathol; 2000 Nov; 192(3):379-84. PubMed ID: 11054722
[TBL] [Abstract][Full Text] [Related]
50. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
51. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
52. Relationship between volume of bathing medium and ectoenzyme activity in monolayers of cultured BPAEC.
Papapetropoulos A; Elmore LA; Catravas JD
Am J Physiol; 1996 Sep; 271(3 Pt 1):L464-9. PubMed ID: 8843796
[TBL] [Abstract][Full Text] [Related]
53. Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits.
Weckler N; Leitzbach D; Kalinowski L; Malinski T; Busch AE; Linz W
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):191-6. PubMed ID: 14608526
[TBL] [Abstract][Full Text] [Related]
54. Effect of a fibrin-derived vasoactive peptide on pulmonary angiotensin converting enzyme activity and on pressure responses to bradykinin.
Moalli R; Saldeen K; Saldeen T
J Pharmacol Exp Ther; 1987 Dec; 243(3):897-900. PubMed ID: 3694536
[TBL] [Abstract][Full Text] [Related]
55. [Influence of lipopolysaccharide on angiotensin converting enzyme activity expressed by human umbilical vein endothelial cells in culture].
Watanabe K; Yoshida M; Jaffe EA
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1214-9. PubMed ID: 2176253
[TBL] [Abstract][Full Text] [Related]
56. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats.
Ninahuaman MF; Souccar C; Lapa AJ; Lima-Landman MT
Phytomedicine; 2007 May; 14(5):321-7. PubMed ID: 17433647
[TBL] [Abstract][Full Text] [Related]
57. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
Kohlstedt K; Brandes RP; Müller-Esterl W; Busse R; Fleming I
Circ Res; 2004 Jan; 94(1):60-7. PubMed ID: 14615289
[TBL] [Abstract][Full Text] [Related]
58. Measurements of serum ACE activity in vitro after administration of enalapril in man cannot reflect inhibition of the enzyme in vivo.
Weisser K; Schloos J
Methods Find Exp Clin Pharmacol; 1993; 15(6):413-8. PubMed ID: 8231461
[TBL] [Abstract][Full Text] [Related]
59. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
[TBL] [Abstract][Full Text] [Related]
60. Bradykinin in ischemia-reperfusion injury of the rat lung.
Nowak K; Weih S; Post S; Gebhard MM; Hohenberger P
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):513-22. PubMed ID: 18204165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
